Original price was: $85.95.$79.95Current price is: $79.95.
For Research Use Purposes Only
Retatrutide is a novel triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors. This innovative approach offers promising research applications in metabolic health, weight management, and glycemic control. Clinical studies have shown significant potential for body weight reduction and improved metabolic markers. It represents the cutting edge of metabolic peptide research.
